News

Merck MRK recently launched two late-stage clinical studies to evaluate MK-8527, its investigational once-monthly oral pill for HIV pre-exposure prophylaxis (PrEP). The EXPrESSIVE-11 study, which ...
Merck MRK announced that the FDA has accepted for review the new drug application (“NDA”) seeking approval for its investigational, once-daily, oral, two-drug, single-tablet regimen of ...
The Dosey Pill Compact is $24 at Amazon and adds a needed dose of style to one of the classic accessories of aging. This flip-top pill organizer is designed more like a sleek sunglasses case and ...
Linzagolix will be the second take-at-home pill to become available on the NHS for treating endometriosis in those that have failed other treatments. In March, Nice also approved relugolix.
A new at-home daily pill for endometriosis has been approved for use on the NHS in England. The tablet, called linzagolix but also known as Yselty, could help more than a thousand women every year ...
A NEW daily pill to treat ‘debilitating and life-limiting’ endometriosis will be rolled on the NHS after getting the green light. The condition – which causes intense pain, extrem… ...
A new at-home treatment option offers hope for women suffering from endometriosis. The NHS has approved linzagolix, also known as Yselty, a once-daily pill designed to alleviate the debilitating ...
A new daily pill treating endometriosis has been approved for use on the NHS in England. The pill, called linzagolix, will soon become available for over 1,000 women to help manage symptoms of the ...
The new smart pill organizer has been co-developed with RxCap and solidifies Centor's position as a leader in innovative drug containment and medication adherence solutions.
A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like Ozempic and Wegovy. In phase III trials it significantly lowered blood ...
A daily pill from drugmaker Eli Lilly has shown similar effectiveness at helping people reduce blood sugar levels and lose weight compared to leading injectable GLP-1 drugs Mounjaro and Ozempic ...
Other weight loss drugs must be injected, meaning the new pill from pharmaceutical giant Eli Lilly could become patients’ top choice if it is approved.